• MJHLS Brand Logo

© 2020 MJH Life Sciences™ and Urology Times. All rights reserved.

Viewpoints

Fresh Perspectives in Overactive Bladder

Overview of Overactive Bladder
Overview of Overactive Bladder
Understanding Patients and Clinical Management of OAB
Understanding Patients and Clinical Management of OAB
Efficacy and Safety of Therapy for Overactive Bladder
Efficacy and Safety of Therapy for Overactive Bladder
Patient and Provider Education on Overactive Bladder
Patient and Provider Education on Overactive Bladder

Evolving Treatment Approaches for Advanced Prostate Cancer

Castration Resistance Monitoring in Prostrate Cancer
Castration Resistance Monitoring in Prostrate Cancer
Bone Health While Receiving ADT For Prostate Cancer
Bone Health While Receiving ADT For Prostate Cancer
Cardiovascular Risk Related to ADT Therapy in Prostate Cancer
Cardiovascular Risk Related to ADT Therapy in Prostate Cancer
Oral LHRH Treatment for Prostate Cancer
Oral LHRH Treatment for Prostate Cancer
Key Data for the Treatment of mCSPC
Key Data for the Treatment of mCSPC
Androgen Receptor Blocker Use in mCSPC
Androgen Receptor Blocker Use in mCSPC
Identifying Appropriate Therapy for Patients in Prostate Cancer
Identifying Appropriate Therapy for Patients in Prostate Cancer
Clinical Trial Data for the Treatment of nmCRPC
Clinical Trial Data for the Treatment of nmCRPC
The Importance of Treating nmCRPC
The Importance of Treating nmCRPC
The Importance of Scans, NGS, and Imaging in nmCRPC
The Importance of Scans, NGS, and Imaging in nmCRPC
Treating Oligometastatic Prostate Cancer
Treating Oligometastatic Prostate Cancer
The Current and Emerging Treatment Landscape of mCRPC
The Current and Emerging Treatment Landscape of mCRPC
Germline and Somatic Testing in mCRPC
Germline and Somatic Testing in mCRPC